NEW YORK (GenomeWeb) – Rheonix announced today it has received an administrative supplement to an existing Small Business Innovation Research Phase I/II grant to develop an automated assay for Zika virus and infection.
The award, which totals $656,414, was granted to Rheonix and collaborators at the New York University College of Dentistry by the National Institute of Dental and Craniofacial Research of the National Institutes of Health.